Korro Bio Statistics
Total Valuation
Korro Bio has a market cap or net worth of $559.14 million. The enterprise value is $409.82 million.
Important Dates
The next estimated earnings date is Wednesday, November 27, 2024, before market open.
| Earnings Date | Nov 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Korro Bio has 9.30 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 9.30M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | +12.06% |
| Owned by Insiders (%) | 6.47% |
| Owned by Institutions (%) | 45.00% |
| Float | 4.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.82 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.28, with a Debt / Equity ratio of 0.19.
| Current Ratio | 13.28 |
| Quick Ratio | 12.77 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -62.72% and return on invested capital (ROIC) is -33.74%.
| Return on Equity (ROE) | -62.72% |
| Return on Assets (ROA) | -31.91% |
| Return on Capital (ROIC) | -33.74% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$836,284 |
| Employee Count | 102 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Korro Bio has paid $47,000 in taxes.
| Income Tax | 47,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 47.12 |
| 200-Day Moving Average | 51.19 |
| Relative Strength Index (RSI) | 56.11 |
| Average Volume (20 Days) | 187,889 |
Short Selling Information
The latest short interest is 274,235, so 2.95% of the outstanding shares have been sold short.
| Short Interest | 274,235 |
| Short Previous Month | 222,784 |
| Short % of Shares Out | 2.95% |
| Short % of Float | 6.18% |
| Short Ratio (days to cover) | 3.91 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -91.62M |
| Pretax Income | -81.17M |
| Net Income | -85.30M |
| EBITDA | -88.27M |
| EBIT | -91.62M |
| Earnings Per Share (EPS) | -$15.11 |
Full Income StatementBalance Sheet
The company has $157.43 million in cash and $38.46 million in debt, giving a net cash position of $149.32 million or $16.06 per share.
| Cash & Cash Equivalents | 157.43M |
| Total Debt | 38.46M |
| Net Cash | 149.32M |
| Net Cash Per Share | $16.06 |
| Equity (Book Value) | 198.08M |
| Book Value Per Share | 21.34 |
| Working Capital | 151.30M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.36 million and capital expenditures -$13.47 million, giving a free cash flow of -$82.84 million.
| Operating Cash Flow | -69.36M |
| Capital Expenditures | -13.47M |
| Free Cash Flow | -82.84M |
| FCF Per Share | -$8.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |